A drug used to treat parasitic liver diseases in animals might hold the key to combating river blindness, a worm-spread eye and skin disease that infects more than 37 million people a year, U.S. researchers say in a study published in the Proceedings of the National Academy of Sciences.

Full Story:

Related Summaries